What Is New in the Management of High-Risk Localized Prostate Cancer?
Open Access
- 6 January 2023
- journal article
- editorial
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (2) , 455
Abstract
The current Special Issue, in the Journal of Clinical Medicine, is dedicated to collecting high-quality research that mainly focuses on “Clinical advances in Prostate Cancer Treatments”Keywords
This publication has 15 references indexed in Scilit:
- Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancerNature Reviews Urology, 2021
- Technical Refinements in Superextended Robot-assisted Radical Prostatectomy for Locally Advanced Prostate Cancer Patients at Multiparametric Magnetic Resonance ImagingEuropean Urology, 2021
- The Epidemiology of Prostate Cancer2021
- Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate dataThe Lancet, 2020
- Immunotherapy in Prostate CancerCancers, 2020
- Recent Advances in the Management of High-Risk Localized Prostate Cancer: Local Therapy, Systemic Therapy, and Biomarkers to Guide Treatment DecisionsAmerican Society of Clinical Oncology Educational Book, 2020
- Preoperative Risk-Stratification of High-Risk Prostate Cancer: A Multicenter AnalysisFrontiers in Oncology, 2020
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone TherapyNew England Journal of Medicine, 2017
- Salvage radical prostatectomy as management of locally recurrent prostate cancer: outcomes and complicationsWorld Journal of Urology, 2013
- Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1998